Insider Selling: Tempus AI, Inc. (NASDAQ:TEM) CEO Sells 85,788 Shares of Stock

Tempus AI, Inc. (NASDAQ:TEM - Get Free Report) CEO Eric P. Lefkofsky sold 85,788 shares of the business's stock in a transaction on Friday, January 24th. The stock was sold at an average price of $53.39, for a total value of $4,580,221.32. Following the transaction, the chief executive officer now owns 5,771,787 shares of the company's stock, valued at $308,155,707.93. This trade represents a 1.46 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this link.

Tempus AI Stock Performance

Tempus AI stock traded down $3.44 during mid-day trading on Friday, hitting $51.40. 12,994,864 shares of the company's stock were exchanged, compared to its average volume of 5,774,415. Tempus AI, Inc. has a 1-year low of $22.89 and a 1-year high of $79.49. The stock has a 50 day moving average of $44.36 and a two-hundred day moving average of $47.59. The company has a current ratio of 2.69, a quick ratio of 2.55 and a debt-to-equity ratio of 8.17.

Analyst Ratings Changes

Several brokerages have recently issued reports on TEM. Wolfe Research assumed coverage on Tempus AI in a research report on Friday, December 13th. They set an "outperform" rating and a $60.00 price target on the stock. Stifel Nicolaus cut shares of Tempus AI from a "buy" rating to a "hold" rating and boosted their price target for the stock from $45.00 to $65.00 in a research report on Monday, November 11th. Bank of America raised their price objective on shares of Tempus AI from $52.00 to $54.00 and gave the company a "neutral" rating in a research report on Friday, December 13th. Guggenheim began coverage on shares of Tempus AI in a report on Monday, December 9th. They issued a "buy" rating and a $74.00 target price on the stock. Finally, Needham & Company LLC restated a "buy" rating and set a $56.00 target price on shares of Tempus AI in a report on Tuesday, January 14th. Three investment analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. According to data from MarketBeat, Tempus AI currently has a consensus rating of "Moderate Buy" and a consensus price target of $56.36.

Institutional Trading of Tempus AI

A number of institutional investors and hedge funds have recently modified their holdings of TEM. First Horizon Advisors Inc. acquired a new position in shares of Tempus AI during the third quarter worth approximately $30,000. FNY Investment Advisers LLC acquired a new position in Tempus AI during the 4th quarter valued at $67,000. Vestor Capital LLC bought a new stake in Tempus AI in the 3rd quarter valued at $153,000. Stifel Financial Corp acquired a new stake in Tempus AI in the 3rd quarter worth $218,000. Finally, IQ EQ FUND MANAGEMENT IRELAND Ltd bought a new position in shares of Tempus AI during the 3rd quarter worth about $258,000. 24.22% of the stock is currently owned by institutional investors and hedge funds.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.